Statement Of Financial Position [Abstract]

ABIVAX - Filing #2810976

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Goodwill
18 419 EUR
18 419 EUR
32 005 EUR
Intangible assets other than goodwill
6 604 EUR
6 607 EUR
93,000 EUR
Cash and cash equivalents
251 942 EUR
26 950 EUR
60 701 EUR
29 302 EUR
Assets
327 062 EUR
75 544 EUR
109 230 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
629,000 EUR
223,000 EUR
168,000 EUR
Share premium
478 218 EUR
150 476 EUR
107 578 EUR
Equity attributable to owners of parent
196 010 EUR
7 189 EUR
Equity
196 010 EUR
135 209 EUR
147 740 EUR
478 218 EUR
629,000 EUR
112,000 EUR
82 770 EUR
60 740 EUR
150 476 EUR
223,000 EUR
EUR
7 189 EUR
42 452 EUR
25 934 EUR
39 361 EUR
25 934 EUR
107 578 EUR
EUR
168,000 EUR
1 733 EUR
143,000 EUR
EUR
2 851 EUR
37 633 EUR
42 073 EUR
Equity and liabilities
327 062 EUR
75 544 EUR
109 230 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.